Interleukin-1beta, antagonists & inhibitors
- Interleukin-1beta, antagonists & inhibitors
- Accession Number
Drug Drug Description Canakinumab An interleukin-1β blocker used to treat Periodic Fever Syndromes such as Cryopyrin-Associated Periodic Syndromes (CAPS) and Familial Mediterranean Fever (FMF), and also to treat active Systemic Juvenile Idiopathic Arthritis (SJIA).
- Drugs & Drug Targets
Drug Target Type Canakinumab Interleukin-1 beta target